ELIZABETH GEORGE: Open Payments
NPI 1942764220 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,050 in 30 payments from 10 companies in 2025. Trend: 2023 $356 · 2024 $589 · 2025 $1,050
Food & beverage: $1,050
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 7 | $510 |
| ABBVIE INC. | 8 | $140 |
| Gilead Sciences, Inc. | 1 | $125 |
| PFIZER INC. | 4 | $77 |
| Janssen Biotech, Inc. | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $46 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
| Lilly USA, LLC | 1 | $28 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: REZDIFFRA, Epclusa, LINZESS, TREMFYA, CREON, ENTYVIO, DUPIXENT, VELSIPITY.
Industry payments across MD — which companies pay providers there.
